Available data support a model in which adipose PKCβ activation is among the initiating
events that disrupt mitochondrial function through interaction with p66shc and amplify fat accumulation and
adipose dysfunction, with systemic consequences. Manipulation of PKCβ levels, activity, or signaling could provide
a therapeutic approach to combat obesity and associated metabolic disorders.
© 2